People Caught Vaping at Qatar 2022 World Cup Face Fines or Prison

Regulations
Jul.25.2022
Vapers heading to this year's World Cup are being warned to refrain from vaping, as any violators will be faced with hefty fines of up to 10,000 riyals (around £2,200) or a maximum of three months in prison.

Brits are being advised to use other quit smoking methods when travelling to Qatar.

People Caught Vaping at Qatar 2022 World Cup Face Fines or Prison

Fans are being urged to check the nicotine consumption rules in Qatar ahead of travelling as it’s prohibited to vape in the country or import vapes. Vaping has been illegal across Qatar since 2014, while data from the UK has indicated that there are approximately 3.3m UK nationals using vapes. To this effect, Brits are being advised to use other quit smoking methods when travelling to Qatar, or else face possible harsh penalties such as fines or a maximum of three months in prison.

 

The warning is being issued by UK online retailer Vape Club, as a large number of UK vapers are also football fans. Given the progressive vape laws in the UK, many of these travelling vapers may mistakenly assume that regulations elsewhere are as permissive.

 

Qatar’s vape ban

In Qatar, using and importing vaping products has been banned since 2014. In 2016, head of the Non-Communicable Disease Department at the Ministry of Public Health Dr Kholood al-Mutawaa, had stated, “The e-cigarette was banned in Qatar according to a ministry order in 2014. We have instructed all supermarkets, pharmacies and other outlets not to sell it. We have also communicated with the customs department at the airport, seaport and the land border not to allow e-cigarettes into Qatar.”

 

“We have instructed all supermarkets, pharmacies and other outlets not to sell it. We have also communicated with the customs department at the airport, seaport and at the borders not to allow e-cigarettes into Qatar. People can’t bring it to the country or order it from other countries. Others can’t send it to the country either. Anyone who is in possession of e-cigarettes may be charged with appropriate action.”

 

Director of Vape Club, Dan Marchant, highlighted that because of the UK’s progressive attitude towards vaping, UK nationals are perhaps more likely than others to unknowingly get in trouble. “Because the UK has such a progressive attitude towards harm reduction and recognises the huge role vaping has to play in achieving a smokefree future, we tend to forget that there are many other countries around the world who are so far behind us. How any country can ban vaping over tobacco use is beyond me, and seems completely anti-science and anti-public health.

 

“I just hope that quitters don’t find themselves turning back to cigarettes in Qatar. There’s a real danger of this. Being deprived of their vapes as a source of nicotine to replace a harmful tobacco product could easily push people back to cigarettes while in Qatar. Once this happens, it could consign the smoker back to months or years of cigarette use before being able to quit again.”

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10